Trials / Completed
CompletedNCT01139905
Lopinavir/Ritonavir (LPV/r) Tablet in HIV Infected Children
Pharmacokinetics of Low- Dose Lopinavir/Ritonavir Tablet Formulation HIV-1 Infected Children
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- The HIV Netherlands Australia Thailand Research Collaboration · Academic / Other
- Sex
- All
- Age
- 1 Year – 18 Years
- Healthy volunteers
- Not accepted
Summary
To study the pharmacokinetics of low-dose lopinavir/ritonavir tablet in HIV-1 infected Thai children.
Detailed description
This is an open-label, single arm study to compare standard dose with a new tablet formulation of a lower dose of lopinavir/ritonavir in HIV-1 infected children.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | lopinavir/ritonavir | standard dose of lopinavir/ritonavir 100/25 mg tablet q 12 hour. |
Timeline
- Start date
- 2010-04-01
- Primary completion
- 2011-03-01
- Completion
- 2011-03-01
- First posted
- 2010-06-09
- Last updated
- 2015-03-26
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT01139905. Inclusion in this directory is not an endorsement.